Chen Juan, Liu Yu, Guo Haijian, Wang Bei, Sun Zilin, Yu Jiangyi
Department of Endocrinology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Medical School, Southeast University, Nanjing, People's Republic of China.
Diabetes Metab Syndr Obes. 2020 Jun 30;13:2297-2305. doi: 10.2147/DMSO.S255908. eCollection 2020.
Obesity is known to be strongly associated with hyperuricemia. Moreover, the impact of urine glucose excretion (UGE) on serum uric acid (UA) levels has gained much more attention in recent years. Yet concern is raised about whether UGE influences the relationship between obesity and hyperuricemia. The aim of this study was to assess the effect of UGE on the association between lipid accumulation product (LAP), a novel marker of visceral adipose accumulation, and UA in subjects with prediabetes.
Data were obtained from a cross-sectional study. A total of 3645 subjects with prediabetes were included in the present study. The separate and joint associations of LAP and UGE with hyperuricemia were examined using logistic regression analyses.
LAP was positively associated with UA in both genders. Subgroup analysis based on UGE revealed that the association was strongest in subjects with low UGE (r = 0.328, p < 0.001), whereas the positive association was weakened, but still remained significant in subjects with moderate and high UGE. High LAP was significantly associated with an increased odds ratio for hyperuricemia after adjustment for potential confounders in the overall population (OR = 2.07, 95% CI: 1.66-2.58, p < 0.001). However, a downward trend in odds ratios for hyperuricemia was observed across UGE categories. In addition, the joint association analysis confirmed that the relationship between LAP and hyperuricemia was attenuated by UGE.
The positive association between LAP and UA appears to be attenuated by UGE, indicating that promoting UGE may be an effective strategy for controlling UA levels, especially for people with obesity who are at increased risk for hyperuricemia.
众所周知,肥胖与高尿酸血症密切相关。此外,近年来尿糖排泄量(UGE)对血清尿酸(UA)水平的影响受到了更多关注。然而,人们担心UGE是否会影响肥胖与高尿酸血症之间的关系。本研究的目的是评估UGE对糖尿病前期患者中内脏脂肪堆积的新标志物——脂质蓄积产物(LAP)与UA之间关联的影响。
数据来自一项横断面研究。本研究共纳入3645例糖尿病前期患者。使用逻辑回归分析检验LAP和UGE与高尿酸血症的单独及联合关联。
LAP在男女两性中均与UA呈正相关。基于UGE的亚组分析显示,在低UGE患者中这种关联最强(r = 0.328,p < 0.001),而在中度和高度UGE患者中,这种正相关虽有所减弱,但仍具有统计学意义。在总体人群中,调整潜在混杂因素后,高LAP与高尿酸血症的比值比显著增加(OR = 2.07,95% CI:1.66 - 2.58,p < 0.001)。然而,在不同UGE类别中观察到高尿酸血症比值比呈下降趋势。此外,联合关联分析证实,UGE减弱了LAP与高尿酸血症之间的关系。
LAP与UA之间的正相关似乎因UGE而减弱,这表明促进UGE可能是控制UA水平的有效策略,尤其是对于肥胖且高尿酸血症风险增加的人群。